A Preliminary Study on the Prognostic Significance of Cysteine-Rich EGF Ligand Domain 2 Protein (CRELD2) in Patients With Triple Negative Breast Cancer. Biomol Biomed 2025. https://doi.org/10.17305/bb.2024.11865.